Clinical trial
A Phase II Study of Oxaliplatin in Patients With Advanced Carcinoma of the Head and Neck
NCT00005035 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Oxaliplatin in Patients With Advanced Carcinoma of the Head and Neck
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 1999
- Completion date
- March 31, 2004
- Enrollment
- Not reported
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer